JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB101500

Anti-CD8 alpha antibody [SP16]

  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • 20ul selling size
  • What is this?

4

(4 Reviews)

|

(83 Publications)

Anti-CD8 alpha antibody [SP16] (ab101500) is a rabbit monoclonal antibody detecting CD8 alpha in Flow Cytometry, IHC-P. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency
- Over 50 publications
- Trusted since 2010

View Alternative Names

CD8a, MAL, CD8A, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [SP16] (AB101500)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [SP16] (AB101500)

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling CD8 alpha with ab101500 at a dilution of 1/100. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab101500 Anti-CD8 alpha antibody [SP16] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II.Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [SP16] (AB101500)
  • mIHC

Collaborator

Multiplex immunohistochemistry - Anti-CD8 alpha antibody [SP16] (AB101500)

10-color fluorescence multiplex immunohistochemical analysis of human lung cancer tissue (formalin-fixed paraffin-embedded section).

Merged staining of anti-FOXP3 (ab215206; Cyan; TG540N), anti-PD1 (ab52587; Red; TG700N), anti-CD163 (ab182422; Brown; TG650N), anti-HLA-DR (ab92511; Yellow; TG570N), anti-CD4 (ab133616; Violet; TG620N), anti-CD8 alpha (ab101500; Purple; TG540S), anti-CD20 (ab9475; Grey; TG660S), anti-CD68 (ab192847; Green; TG520N), anti-Cytokeratin 19 (ab52625; Light blue; TG440N). TG470SN (dark blue) was used as a nuclear counter stain. The inset image shows the separate CD68 signal.

The section was incubated in nine rounds of staining; in the order of ab215206 (1/100 dilution), ab52587 (1/200 dilution), ab182422 (1/300 dilution), ab92511 (1/200 dilution), ab133616 (1/600 dilution), ab101500 (1/300 dilution), ab9475 (1/100 dilution), ab192847 (1/300 dilution), ab52625 (1/400 dilution); each using a separate fluorescent tyramide signal amplification system.

Sodium citrate antigen retrieval (pH6.0) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity.

Image acquisition was performed with TissueFAXS Spectra (TissueGnostics).

This image is courtesy of TissueGnostics Asia Pacific Limited

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [SP16] (AB101500)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [SP16] (AB101500)

Immunohistochemical analysis of paraffin-embedded Human tonsil labeling CD8 with ab101500 at 1/100 (21 μg/ml). The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab101500 for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. DAB was used as the chromogen. Counterstained with Hematoxylin and mounted with DPX.

Flow Cytometry - Anti-CD8 alpha antibody [SP16] (AB101500)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-CD8 alpha antibody [SP16] (AB101500)

This image was generated using a previous batch manufactured using hybridoma production method.

Human peripheral blood lymphocytes staining CD8 alpha with ab101500 (red line). Human whole blood was processed using a modified protocol based on Chow et al, 2005 (PMID : 16080188). In brief, human whole blood was fixed in 4% formaldehyde (methanol-free) for 10 min at 22°C. Red blood cells were then lysed by the addition of Triton X-100 (final concentration - 0.1%) for 15 min at 37°C. For experimentation, cells were treated with 50% methanol (-20°C) for 15 min at 4°C. Cells were then incubated with the antibody (ab101500, 1/1000 dilution) for 30 min at 4°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 4°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >30,000 total events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. Gating strategy - peripheral blood lymphocytes.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

SP16

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Epitope

C-terminus

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p>Boil tissue section in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at room temperature for 20 min.</p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/1000", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

Product Specifications
Anti-CD8 alpha antibody [SP16] (ab101500) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cyt, IHC-P in human samples.
Anti-CD8 alpha antibody [SP16] (ab101500) specifically detects CD8 alpha (UniProt ID: P01732; Molecular weight: 24kDa) and is sold in 100 µL, 500 µL and 1 mL selling sizes.

Quality and Validation
Anti-CD8 alpha antibody [SP16] (ab101500) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC).
Abcam's high quality manufacturing and validation processes ensure Anti-CD8 alpha antibody [SP16] (ab101500) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-CD8 alpha antibody [SP16] (ab101500) has been cited over 53 times in peer reviewed journals and is trusted by the scientific community.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD8 alpha also known as CD8A or CD8 protein is a glycoprotein subunit expressed on the surface of cytotoxic T lymphocytes. It has a mass of approximately 32 kDa. Found on the surface cell membrane CD8 alpha functions primarily in the immune response specifically in the recognition of antigens bound to major histocompatibility complex (MHC) class I molecules. Often scientists use CD8 antibodies for detection and CD8 IHC or immunohistochemistry for localization studies.
Biological function summary

The CD8 alpha protein plays a critical role in T-cell mediated immune responses. It forms a heterodimer with the CD8 beta chain creating the CD8 alpha-beta complex that strengthens T-cell interaction with antigen-presenting cells. CD8 alpha also helps in signaling processes that activate T cells equipping them to destroy infected or malignant cells. Researchers often study CD8 alpha peptides to understand its interactions better.

Pathways

CD8 alpha is integral to the T-cell receptor signaling pathway and the cytotoxic T lymphocyte (CTL) pathway. The T-cell receptor complex which includes the CD8 molecule transmits signals that are important for T-cell activation and function. CD8 interacts with key proteins such as the T-cell receptor (TCR) and MHC class I molecules facilitating targeted responses against pathogens. These pathways highlight CD8 alpha’s role in adaptive immunity.

CD8 alpha is most prominently associated with viral infections and cancer. Conditions like HIV and some forms of leukemia show altered CD8 function highlighting the protein's role in immune surveillance. In HIV infection for instance CD8 T cells reduce in number impairing the immune response. CD8 alpha’s connection to the immune system places it alongside other immune proteins such as CD4 and MHC molecules in the context of immune dysfunction.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The protein expressed by the gene CD8A is an integral membrane glycoprotein crucial for immune responses, operating mainly in T-cells as a coreceptor for MHC class I molecule : peptide complexes. These peptides originate from cytosolic proteins, unlike class II peptides, which are from extracellular proteins. CD8A interacts with the T-cell receptor (TCR) and MHC class I proteins on antigen-presenting cells, recruiting the Src kinase LCK to the TCR-CD3 complex. LCK phosphorylates substrates, triggering signaling pathways that lead to the production of lymphokines, enhanced motility, adhesion, and activation of cytotoxic T-lymphocytes (CTLs), thereby aiding in the recognition and elimination of infected or tumor cells. Additionally, in natural killer (NK) cells, CD8A homodimers on the cell surface provide a survival mechanism for conjugating with and lysing multiple target cells. CD8A homodimers also facilitate the survival and differentiation of activated lymphocytes into memory CD8 T-cells. This supplementary information is collated from multiple sources and compiled automatically.
See full target information CD8A

Publications (83)

Recent publications for all applications. Explore the full list and refine your search

Current issues in molecular biology 47: PubMed41020815

2025

The Axis Modulates the Immunosuppressive Tumor Microenvironment and Predicts Immunotherapy Response in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenxing Wang,Xia Li,Shiyi Zhang,Jiamin Sun,Qinchen Lu,Yuting Tao,Shuang Liang,Xiuwan Lan,Jianhong Zhong,Qiuyan Wang

JCI insight 10: PubMed40985894

2025

FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaolong Xu,Bin Shang,Hancheng Wu,Xiuye Jin,Junren Wang,Jing Li,Daowei Li,Bin Liang,Xingguang Wang,Lili Su,Wenjie You,Shujuan Jiang

Medical sciences (Basel, Switzerland) 13: PubMed40981193

2025

Mast Cell Association with the Microenvironment of a Phosphaturic Mesenchymal Tumour Secreting Fibroblast Growth Factor 23.

Applications

Unspecified application

Species

Unspecified reactive species

Andrey Kostin,Alexei Lyundup,Alexander Alekhnovich,Aleksandra Prikhodko,Olga Patsap,Sofia Gronskaia,Zhanna Belaya,Olga Lesnyak,Galina Melnichenko,Natalia Mokrysheva,Igor Buchwalow,Markus Tiemann,Dmitrii Atiakshin

NPJ breast cancer 11:67 PubMed40624019

2025

NR4A3 potentials M1-like macrophage polarization to facilitate anti-tumor immune responses in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Yu Qian,Ning Jin,Shan-Shan Rao,Ya Wang,Xin Li,Wen Pan,Pu Huang,Si-Yuan Wang,Ping-Fei Li,Yan-Kai Lv,Qing-Lei Gao,Yu Xia

NPJ precision oncology 9:184 PubMed40517137

2025

Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zoe I Day,Samuel Roberts-Thomson,Yasmin J Nouri,Nathan S Dalton,Stacie S Wang,Alexander Davenport,Louise E Ludlow,Mark D Hulett,Ryan S Cross,Misty R Jenkins

The Journal of clinical investigation 135: PubMed40166933

2025

ACAT1 regulates tertiary lymphoid structures and correlates with immunotherapy response in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Mengxia Jiao,Yifan Guo,Hongyu Zhang,Haoyu Wen,Peng Chen,Zhiqiang Wang,Baichao Yu,Kameina Zhuma,Yuchen Zhang,Jingbo Qie,Yun Xing,Pengyuan Zhao,Zihe Pan,Luman Wang,Dan Zhang,Fei Li,Yijiu Ren,Chang Chen,Yiwei Chu,Jie Gu,Ronghua Liu

Cancer cell international 25:84 PubMed40057713

2025

The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Sheng Qiu,Hongdong Han,Hongmin Zhang,Mengliu Yang,Hao Wang,Ke Li,Ling Li,Gangyi Yang

Open forum infectious diseases 12:ofaf047 PubMed40046890

2025

HIV-related Differences in Placental Immunology: Data From the PRACHITi Cohort in Pune, India.

Applications

Unspecified application

Species

Unspecified reactive species

Jyoti S Mathad,Mallika Alexander,Ramesh Bhosale,Shilpa Naik,Lisa Marie Cranmer,Vandana Kulkarni,Sydney Busch,Andrea Chalem,Emily Gitlin,Jun Lei,Anguo Liu,Jin Liu,Yang Liu,Rupak Shivakoti,Amita Gupta,Irina Burd

Journal of translational medicine 23:197 PubMed39966857

2025

Integrative analysis of T cell-mediated tumor killing-related genes reveals KIF11 as a novel therapeutic target in esophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xinxin Cheng,Huihui Zhao,Zhangwang Li,Liping Yan,Qingjie Min,Qingnan Wu,Qimin Zhan

Journal of translational medicine 23:107 PubMed39844178

2025

Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Tong Wu,Lin Fang,Yuli Ruan,Mengde Shi,Dan Su,Yue Ma,Ming Ma,Bojun Wang,Yuanyu Liao,Shuling Han,Xiaolin Lu,Chunhui Zhang,Chao Liu,Yanqiao Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com